[go: up one dir, main page]

BR9810046A - Nucleotide sequence, expression vector, host cell, mammalian sperm protein, recombinant sperm protein, sperm protein 4, 1 and / or 6.7, pharmaceutical composition, and contraceptive vaccine - Google Patents

Nucleotide sequence, expression vector, host cell, mammalian sperm protein, recombinant sperm protein, sperm protein 4, 1 and / or 6.7, pharmaceutical composition, and contraceptive vaccine

Info

Publication number
BR9810046A
BR9810046A BR9810046-7A BR9810046A BR9810046A BR 9810046 A BR9810046 A BR 9810046A BR 9810046 A BR9810046 A BR 9810046A BR 9810046 A BR9810046 A BR 9810046A
Authority
BR
Brazil
Prior art keywords
sperm protein
mammalian
host cell
expression vector
nucleotide sequence
Prior art date
Application number
BR9810046-7A
Other languages
Portuguese (pt)
Inventor
Marcel Van Duin
Arij Jan Grootenhuis
Robert John Aitken
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of BR9810046A publication Critical patent/BR9810046A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"SEQUêNCIA DE NUCLEOTìDEOS, VETOR DE EXPRESSãO, CéLULA HOSPEDEIRA, PROTEìNA DE ESPERMA DE MAMìFERO, E, VACINA CONTRACEPTIVA" A presente invenção refere-se a proteínas 4,1 e 6,7 específicas de mamífero, e sequências de nucleotídeos codificando referidas proteínas, bem como formulações farmacêuticas, em particular vacinas compreendendo referidas proteínas. As proteínas 4,1 e 6,7 são específicas de esperma e podem ser usadas em uma vacina para evitar ou reduzir fertilidade em indivíduos."NUCLEOTIDE SEQUENCE, EXPRESSION VECTOR, HOST CELL, MAMMALIAN SPERM PROTEIN, AND, CONTRACEPTIVE VACCINE" The present invention relates to mammalian-specific 4.1 and 6.7 proteins, and nucleotide sequences encoding said proteins, as well as pharmaceutical formulations, in particular vaccines comprising said proteins. Proteins 4.1 and 6.7 are sperm specific and can be used in a vaccine to prevent or reduce fertility in individuals.

BR9810046-7A 1997-06-19 1998-06-17 Nucleotide sequence, expression vector, host cell, mammalian sperm protein, recombinant sperm protein, sperm protein 4, 1 and / or 6.7, pharmaceutical composition, and contraceptive vaccine BR9810046A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97201863 1997-06-19
PCT/EP1998/004016 WO1998058954A2 (en) 1997-06-19 1998-06-17 Sperm specific antigens 4.1 and 6.7, dna encoding them and contraceptive vaccines comprising said sperm antigens

Publications (1)

Publication Number Publication Date
BR9810046A true BR9810046A (en) 2000-08-29

Family

ID=8228457

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9810046-7A BR9810046A (en) 1997-06-19 1998-06-17 Nucleotide sequence, expression vector, host cell, mammalian sperm protein, recombinant sperm protein, sperm protein 4, 1 and / or 6.7, pharmaceutical composition, and contraceptive vaccine

Country Status (6)

Country Link
EP (1) EP1012176A1 (en)
JP (1) JP2002505583A (en)
AU (1) AU8339898A (en)
BR (1) BR9810046A (en)
CA (1) CA2296002A1 (en)
WO (1) WO1998058954A2 (en)

Also Published As

Publication number Publication date
WO1998058954A2 (en) 1998-12-30
WO1998058954A3 (en) 1999-03-18
AU8339898A (en) 1999-01-04
EP1012176A1 (en) 2000-06-28
JP2002505583A (en) 2002-02-19
CA2296002A1 (en) 1998-12-30

Similar Documents

Publication Publication Date Title
BR9809445A (en) Polypeptide comprising an immunogenic portion of a m antigen. tubercolosis, dna molecule, expression vector, host cell, pharmaceutical composition, vaccine, fusion protein, processes for inducing protective immunity in a patient, tuberculosis detection process in a patient, and, diagnostic kit.
AR006188A1 (en) "PHARMACEUTICAL COMPOSITION TO INHIBIT SERINPROTEASE ACTIVITY, IN VITRO METHOD TO INHIBIT SERINPROTEASE ACTIVITY AND METHOD TO PREPARE SUCH COMPOSITION".
BR0007414A (en) Expression and export of anti-obesity proteins as fc fusion proteins
DK0559884T4 (en) Recombinant viral vectors for expression in muscle cells
ATE184052T1 (en) GDF-1 AND UOG1 PROTEINS
CY1106350T1 (en) TUBERCULOSIS VACCINE
AR062300A2 (en) POLYPEPTIDE THAT INCLUDES AN IMMUNOGENIC PORTION OF A PROSTATE PROTEIN OR ITS VARIANT, DNA MOLECULA, EXPRESSION VECTOR, CELL PHONE PHARMACEUTICAL COMPOSITION, VACCINE USE OF SUCH COMPOSITIONS AND VACCINES TO PREPARE MEDICINES
FI932678A0 (en) Pao alfavirus baserande DNA expression system
BR9712518A (en) Polypeptide, DNA molecule, expression vector, host cell, pharmaceutical composition, vaccine, fusion protein, process for detecting tuberculosis in a patient, and diagnostic kit
NZ503763A (en) Antigenic compositions and vaccines comprising a high molecular weight (HMW) protein of Clamydia for therapeutic and prophylactic use
BR0107703A (en) Recombinant flaviviruses and processes for their use
DE69939327D1 (en) FUNCTIONAL ANTAGONISTS OF HEDGEHOG ACTIVITY
BR9803960A (en) D-sorbitol dehydrogenase gene.
BR0010563A (en) Isolated skin cell compositions and methods for their use
ES2146214T3 (en) VACCINES FOR ACTINOBACILLUS PLEUROPNEUMONIAE.
BR0009170A (en) akt nucleic acids, polypeptides and their use
BR0016129A (en) Nucleic acid molecule, recombinant vector, polypeptide, eukaryotic amino acid racemase, antibodies, host cell, methods to produce polypeptide, to detect a parasite and a eukaryotic protein, to screen active molecules, to detect and quantify the presence or absence of a sequence, to inhibit a eukaryotic protein, to produce a eukaryotic and d-aminoacid recombinant amino acid racemase and to prevent or inhibit infection, plasmid, immune complex, kit to detect a parasite, fragment of a polynucleotide, eukaryotic protein, processes to prepare a purified eukaryotic protein, to detect an infection and for infection and to screen a molecule, immunizing composition, vaccine composition, any molecular modification of the gene or a fragment of the gene, use of any molecular or biochemical modification of the enzymatic activity of the racemase, and , any molecule or composition to
NO992158L (en) Nucleic acid and amino acid sequences associated with Heliobacter Pylori and vaccine preparations thereof.
ATE319833T1 (en) VACCINES TO INCREASE IMMUNE RESPONSES AGAINST HERPES SIMPLEX VIRUS
BR9812138A (en) Methods and compositions for therapies employing genes encoding secreted proteins such as interferon-beta
ATE357526T1 (en) MODIFIED HCV PEPTIDE VACCINES
BRPI0410655A (en) pharmaceutical composition, method of treating or preventing a rabies virus infection in an individual in need of this treatment, recombinant rhabdovirus expression vector, mammalian host cell, method of producing a recombinant human rabies virus neutralizing antibody in a mammal, and, use of a combination
BR9810046A (en) Nucleotide sequence, expression vector, host cell, mammalian sperm protein, recombinant sperm protein, sperm protein 4, 1 and / or 6.7, pharmaceutical composition, and contraceptive vaccine
DK0805204T3 (en) Biticle - specifically receptor protein and its use
BR0303362A (en) Composition and method for enhancing an immune response in an animal, method for distributing a load protein in an animal cell, genetically modified living cell, and method for constructing a fusion protein for improving an immune response in an animal

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired